Greg Winter

Sir Greg Winter

CBE FRS FMedSci
Sir Greg Winter; CBE FRS FMedSci
	Gregory Winter in December 2018
Born	14 April 1951 (age 73); Leicester, Leicestershire, U.K.
Education	Royal Grammar School, Newcastle upon Tyne
Alma mater	University of Cambridge (MA, PhD)
Known for	Cambridge Antibody Technology; Domantis; Bicycle Therapeutics; Antibody engineering;
Awards	Colworth Medal (1986); EMBO Member (1987); Louis-Jeantet Prize for Medicine (1989); Knight Bachelor (2004); Royal Medal (2011); Prince Mahidol Award (2016); Nobel Prize in Chemistry (2018);
	Scientific career
Fields	Biochemistry
Institutions	University of Cambridge; Laboratory of Molecular Biology;
Thesis	The amino acid sequence of tryptophanyl tRNA synthetase from Bacillus stearothermophilus (1977)
Doctoral advisor	Brian S. Hartley; George Brownlee;
Website	trin.cam.ac.uk/about/master-fellows/master/winter/

Sir Gregory Paul Winter CBE FRS FMedSci (born 14 April 1951) is a British biochemist. He is best known for his work on the therapeutic use of monoclonal antibodies. He invented techniques to both humanise (1986) and, later, to fully humanise using phage display, antibodies for therapeutic uses.^[5]

Winter won the 2018 Nobel Prize in Chemistry along with George P. Smith and Frances Arnold.^[6]

References change

↑ WINTER, Sir Gregory (Paul). Who's Who. Vol. 2016 (online Oxford University Press ed.). A & C Black, an imprint of Bloomsbury Publishing plc. {{cite book}}: |website= ignored (help) (subscription required)
↑ "EMBO MEMBER: Gregory P. Winter". people.embo.org.
↑ "Announcement of the Prince Mahidol Award 2016". princemahidolaward.org. Archived from the original on 2017-11-14. Retrieved 13 June 2017.
↑ "Nobel Prize in Chemistry 2018 - live". The Guardian. 3 October 2018. Retrieved 3 October 2018.
↑ McCafferty, J.; Griffiths, A.; Winter, G.; Chiswell, D. (1990). "Phage antibodies: filamentous phage displaying antibody variable domains". Nature. 348 (6301): 552–554. Bibcode:1990Natur.348..552M. doi:10.1038/348552a0. PMID 2247164. S2CID 4258014.
↑ "Live blog: direction evolution takes chemistry Nobel prize". Retrieved 3 October 2018.

This short article about a person or group of people can be made longer. You can help Wikipedia by adding to it.

[whoswho-1] WINTER, Sir Gregory (Paul). Who's Who. Vol. 2016 (online Oxford University Press ed.). A & C Black, an imprint of Bloomsbury Publishing plc. {{cite book}}: |website= ignored (help) (subscription required)

[membo-2] "EMBO MEMBER: Gregory P. Winter". people.embo.org.

[3] "Announcement of the Prince Mahidol Award 2016". princemahidolaward.org. Archived from the original on 2017-11-14. Retrieved 13 June 2017.

[4] "Nobel Prize in Chemistry 2018 - live". The Guardian. 3 October 2018. Retrieved 3 October 2018.

[5] McCafferty, J.; Griffiths, A.; Winter, G.; Chiswell, D. (1990). "Phage antibodies: filamentous phage displaying antibody variable domains". Nature. 348 (6301): 552–554. Bibcode:1990Natur.348..552M. doi:10.1038/348552a0. PMID 2247164. S2CID 4258014.

[nobel-1-6] "Live blog: direction evolution takes chemistry Nobel prize". Retrieved 3 October 2018.

[5]

[1]

[2]

[3]

[4]

[6]

Sir Greg Winter CBE FRS FMedSci
Gregory Winter in December 2018
Born	(1951-04-14) 14 April 1951 (age 73)^[1] Leicester, Leicestershire, U.K.
Education	Royal Grammar School, Newcastle upon Tyne
Alma mater	University of Cambridge (MA, PhD)
Known for	Cambridge Antibody Technology Domantis Bicycle Therapeutics Antibody engineering
Awards	Colworth Medal (1986) EMBO Member (1987)^[2] Louis-Jeantet Prize for Medicine (1989) Knight Bachelor (2004) Royal Medal (2011) Prince Mahidol Award (2016)^[3] Nobel Prize in Chemistry (2018)^[4]
Scientific career
Fields	Biochemistry
Institutions	University of Cambridge Laboratory of Molecular Biology
Thesis	The amino acid sequence of tryptophanyl tRNA synthetase from Bacillus stearothermophilus (1977)
Doctoral advisor	Brian S. Hartley George Brownlee

Website	trin.cam.ac.uk/about/master-fellows/master/winter/